Ainslie Parsons
Bereskin & Parr LLP
Broad Institute Prevails in Recent Round of the US CRISPR Patent Battle
USA - September 26 2018 Control of intellectual property covering the CRISPRCas9 (CRISPR) gene editing system continues to be hotly contested. CRISPR is a powerful...
The Battle to Control CRISPR IP Continues
USA - August 2 2018 The CRISPRCas9 system allows specific “editing” of genes in living cells and organisms using in part a cell’s own machinery. This system has already...
Medical Device Ads - Ad Standards is Now Open for Business
Canada - March 5 2018 On January 2, 2018, Ad Standards began reviewing and issuing approval numbers for ads for medical devices that comply with Guidelines for Consumer...
Marketing “Unhealthy Food” to Children: Legislators Move on an Initiative that Industry Voluntarily Put in Place in 2007
Canada - March 5 2018 Health Canada is proposing to restrict the marketing of food containing certain levels of saturated fat, sugars or sodium (“unhealthy” food) to...
Evolution of the Common General Knowledge: Humanized Antibody Claims Upheld at the Canadian Patent Appeal Board
Canada - August 26 2016 Applicants prevailed in the recent Commissioner’s Decision Re Chugai Seiyaku and Kabushiki Kaisha (CD 1398, hereinafter “Kaisha”) 1 from the Patent...
